Hematology/Oncology

Top Story

Cabozantinib induces antitumor activity for radioiodine-refractory thyroid cancer

Cabozantinib induces antitumor activity for radioiodine-refractory thyroid cancer
February 19, 2018
Meeting News

‘Encouraging’ results with JCAR017 for relapsed, refractory lymphoma

February 19, 2018
High-risk patients with relapsed and refractory diffuse large B-cell lymphoma who received JCAR17 chimeric antigen receptor T-cell therapy had an overall response rate…
Meeting NewsPerspective

Racial disparities persist in stem cell transplant for multiple myeloma

February 19, 2018
ATLANTA — More non-Hispanic whites underwent hematopoietic stem cell transplant for initial therapy for multiple myeloma compared with non-Hispanic blacks…
In the Journals

Cigar, pipe smoking significantly elevates mortality risk

February 19, 2018
Smoking cigars and pipes are associated with a significantly increased risk for death from tobacco-related cancers, as well as cardiovascular causes, according to…
In the Journals Plus

Fracture incidence in thyroid cancer linked to levothyroxine dose

February 19, 2018
Adults with thyroid cancer taking less than 115 µg per day or at least 145 µg per day of levothyroxine after thyroidectomy or radioiodine ablation therapy had an…
More Headlines »
CME

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »
Video
Meeting News

VIDEO: Studies may lead to ‘era’ where chemotherapy is not needed for lymphoma subtype

December 15, 2017
More »
Resource Centers
BMT Tandem Meetings

BMT Tandem Meetings

CME

Immune Checkpoint Inhibitors in Advanced Melanoma: What You May Have Missed in Madrid

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incidence of melanoma in the United States continues to rise as demonstrated by the Surveillance, Epidemiology and…
More »
Current Issues
View the Current Issue
HemOnc Today